A Controlled Trial of Educational Outreach to Improve Blood Transfusion Practice

作者: Stephen B Soumerai , Susanne Salem-Schatz , Jerry Avorn , Christina S Casteris , Dennis Ross-Degnan

DOI: 10.1001/JAMA.1993.03510080065033

关键词:

摘要: Objective. —To determine whether brief, face-to-face educational outreach visits can improve the appropriateness of blood product utilization. Design. —Randomized, controlled multicenter trial with 6-month follow-up. Setting. —Surgical and medical services two pairs matched community teaching hospitals in Massachusetts. Participants. —One hundred one transfusing staff surgeons attending physicians. Intervention. —A professionally based transfusion specialist presented surgical- or medical-service—wide lecture emphasizing appropriate indications, risks, benefits red cell transfusions; graphic, printed guidelines; 30-minute visit each physician. No data feedback was provided. Educational messages emphasized lack utility traditional threshold for transfusions (hematocrit, 30%) risks (eg, viral hepatitis). Measures. —Proportion classified as compliant noncompliant guidelines, indeterminate 6 months before after an experimental intervention. Results. —Based on analyses 1449 record audits that occurred intervention, average proportion not compliance criteria declined from 0.40 to 0.24 among study (-40%) compared increase 0.44 (+9%) control (P=.006). These effects were consistent across procedure type specialty. On average, postintervention period performed when hematocrits 2.0 percentage points lower than intervention (28.3% preintervention vs 26.3% postintervention), group postintervention;P=.04). Likely savings use surgical probably exceeded program costs, even without considering reduced infection. observed occurring services, possibly because substantially rates pretransfusion hematocrits. Conclusions. —Brief, focused by specialists cost-effectiveness surgery. More are needed regarding durability changes practice patterns health economic such interventions. (JAMA. 1993;270:961-966)

参考文章(24)
Harvey J. Alter, Chronic Consequences of Non-A, Non-B Hepatitis Current Perspectives in Hepatology. pp. 83- 97 ,(1989) , 10.1007/978-1-4684-7041-3_8
Stephen B. Soumerai, Jerry Avorn, Efficacy and Cost-Containment in Hospital Pharmacotherapy: State of the Art and Future Directions Milbank Quarterly. ,vol. 62, pp. 447- 474 ,(1984) , 10.2307/3349860
Wayne A Ray, William Schaffner, Charles F Federspiel, Persistence of improvement in antibiotic prescribing in office practice. JAMA. ,vol. 253, pp. 1774- 1776 ,(1985) , 10.1001/JAMA.1985.03350360100028
B Mozes, M Epstein, I Ben-Bassat, B Modan, H Halkin, Evaluation of the appropriateness of blood and blood product transfusion using preset criteria. Transfusion. ,vol. 29, pp. 473- 476 ,(1989) , 10.1046/J.1537-2995.1989.29689318442.X
Ira E. Raskin, Claire W. Maklan, Medical treatment effectiveness research. A view from inside the Agency for Health Care Policy and Research. Evaluation & the Health Professions. ,vol. 14, pp. 161- 186 ,(1991) , 10.1177/016327879101400203
Douglas MacN. Surgenor, Edward L. Wallace, Steven H.S. Hao, Richard H. Chapman, Collection and Transfusion of Blood in the United States, 1982–1988 New England Journal of Medicine. ,vol. 322, pp. 1646- 1651 ,(1990) , 10.1056/NEJM199006073222306
N Blumberg, J Laczin, A McMican, J Heal, D Arvan, A critical survey of fresh-frozen plasma use. Transfusion. ,vol. 26, pp. 511- 513 ,(1986) , 10.1046/J.1537-2995.1986.26687043615.X
Stephen B Soumerai, Jerry Avorn, Principles of Educational Outreach ('Academic Detailing') to Improve Clinical Decision Making JAMA: The Journal of the American Medical Association. ,vol. 263, pp. 549- 556 ,(1990) , 10.1001/JAMA.1990.03440040088034